Study details
Enrolling now
CARES-Spine Trial
Stanford University
NCT IDNCT06027099ClinicalTrials.gov data as of Apr 2026
Phase
Phase 3
Target enrollment
375
Study length
about 3.7 years
Ages
18–64
Locations
1 site in CA
About this study
This trial is testing a treatment to help people who have had back surgery stop taking opioids and manage their pain. The treatment includes motivational interviewing, guided opioid tapering support, or placebo compared to enhanced usual care.
Based on ClinicalTrials.gov records.
What participants do
- 1.Participate in Enhanced Usual Care
- 2.Participate in MI-Opioid Taper
- 3.Take Placebo
- +1 more
PhasePhase 3
DrugTizanidine
Routeoral
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low12%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
tizanidine
Drug routes
oral (Oral Capsule)
Body systems
Psychiatry / Mental Health